CMS is part of the new Law journal for pharma, biotech, and medtech

We are pleased to announce that two of our life sciences team members, Felix Kesselring and Marion Wyler, are supporting the new Law journal for pharma, biotech, and medtech ("Life Science Recht") as reporters. The journal deals with legal issues in the fields of pharmaceuticals, biotech and medtech. The contents are written in English, German and French.

For details on the new journal, see here.
The first issue is available free of charge, see here.